U.S. adoption rate exceeds 97 percent; Monte Carlo dose calculation extends CyberKnife® System's capabilities in precision radiation delivery for lung tumors.
Despite reimbursement, barriers remain
The workhorse of molecular imaging and companies that provide sales and service.
Autopsies inform cardiac imaging technique in ACC research
Rate of lung cancer and heart attack spikes for these patients
The year's biggest event for nuclear medicine and molecular imaging
Researchers use PET probes to visualize treatments through cell surface signaling
Will cath labs replace TAVRs?
The debate is over; nearly all scientists (and politicians) agree that climate change is real and is the result of human activity.
Former neurosurgery chairman of Henry Ford Health System joins NICO Corporation board of directors
Blackford platform already provides a range of tools
High risk, high reward screening must be approached on an individual basis
Sally Schwarz has worked in nuclear medicine in many roles and began her career in the field when it was just starting to grow
This month's best products in OR Suite
High dose rate brachytherapy treatment enables prostate cancer patients to avoid overnight hospital stay.
How the MITA Smart Dose Standard is ruling the CT Market
A candid and wide-reaching overview of passing thoughts and lingering takeaways from RSNA 2016
Technology and techniques get revamped to increase the return on investment
Acquires information based on 53 data points to predict rate and length of survival
FastForward 1812 is a $65 million innovation hub
Sofinnova Partners appoints venture partner
Researchers find sufficient evidence to support routine screening
Greg Morrison gives a macro-view of what the facts and trends coming out of RNSA 2006 mean -- and he sees CT technology, in particular, moving into every area of both diagnostic imaging and therapy in a big way.
Commercial launch of AutovaxID™ will enable personalized cell-derived therapies.
Study finds CT for pediatric falls doubled between 2001 and 2010
